|
Status |
Public on Oct 25, 2021 |
Title |
RNA-seq using mouse Neuro-2A (N2A) neuroblastoma cells |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
To identify high-confidence NMD targets in mouse N2A neuroblastoma cells, we used our established transcriptome-wide RNA sequencing (RNA-seq) methodologies. Through parallel analyses of RNA-seq upon UPF1-knockdown (KD) and RNA immunoprecipitation (RIP-seq) footprinting of p-UPF1-bound RNAs, we identified 1027 high-confidence neuronal NMD targets.
|
|
|
Overall design |
RNA profiles of N2A cells treated with control siRNA (siCtl; n=2) or Upf1 siRNA (siUpf1; n=3).
|
|
|
Contributor(s) |
Kurosaki T, Maquat LE |
Citation(s) |
34784943 |
BioProject |
PRJNA745214 |
|
Submission date |
Jul 14, 2021 |
Last update date |
Nov 30, 2021 |
Contact name |
Tatsuaki Kurosaki |
E-mail(s) |
[email protected]
|
Phone |
5852812657
|
Organization name |
University of Rochester
|
Department |
Biochemistry and Biophysics
|
Lab |
Lynne Maquat lab
|
Street address |
601 Elmwood Avenue, Box 712
|
City |
Rochester |
State/province |
NY |
ZIP/Postal code |
14642 |
Country |
USA |
|
|
Platforms (1) |
GPL30028 |
illumina NovaSeq 6000 (Mus musculus) |
|
Samples (5)
|
|
This SubSeries is part of SuperSeries: |
GSE180137 |
NMD abnormalities during brain development in the Fmr1-knockout mouse model of fragile X syndrome |
|